Skip to main content

Table 2 Platelet reactivity and HRPR according to TyG index quartiles

From: Triglyceride glucose index influences platelet reactivity in acute ischemic stroke patients

Characteristics Q1 (< 2.02) (n = 250) Q2 (2.02–2.27) (n = 251) Q3 (2.27–2.52) (n = 251) Q4 (≥2.52) (n = 250) P Value
MA (mm) 61.8 [57.8–65.2] 62.1 [58.2–65.5] 62.7 [59.2–66.3] 63.1 [59.7–66.5] 0.004
MAADP (mm) 30.9 [18.1–42.5] 31.0 [16.8–41.3] 31.6 [18.6–42.5] 30.0 [18.3–42.2] 0.645
ADP% (%) 58.4 [39.1–81.4] 60.2 [40.1–85.1] 58.2 [35.5–82.3] 61.6 [41.9–86.0] 0.306
AA% (%) 99.0 [87.2–100] 97.4 [83.7–100] 96.2 [77.9–100] 93.0 [70.0–98.9] < 0.001
Clopidogrel HRPR, n (%) 40 (16.0) 43 (17.1) 54 (21.5) 51 (20.4) 0.338
Aspirin HRPR, n (%) 18 (7.2) 30 (12.0) 37 (14.7) 45 (18.0) 0.003
  1. Data given as n (%) or median [interquartile range]
  2. Abbreviations: TyG index triglyceride glucose index, Q1–Q4 TyG index quartiles, MA maximum amplitude, MAADP ADP-induced platelet-fibrin clot maximum amplitude, ADP% inhibition rate of adenosine diphosphate (ADP), AA% inhibition rate of arachidonic acid (AA), HRPR high residual on-treatment platelet reactivity